These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15576286)
1. The relevance of therapeutic drug monitoring in plasma and erythrocytes in anti-cancer drug treatment. Dumez H; Guetens G; De Boeck G; Highley MS; Maes RA; van Oosterom AT; de Bruijn EA Clin Chem Lab Med; 2004; 42(11):1219-27. PubMed ID: 15576286 [TBL] [Abstract][Full Text] [Related]
2. Everolimus alters imatinib blood partition in favour of the erythrocyte. Prenen H; Guetens G; De Boeck G; Highley M; van Oosterom AT; de Bruijn EA J Pharm Pharmacol; 2006 Aug; 58(8):1063-6. PubMed ID: 16872552 [TBL] [Abstract][Full Text] [Related]
3. Application of liquid chromatography-mass spectrometry to monitoring plasma cyclophosphamide levels in phase I trial cancer patients. Liu JJ; Kestell P; Findlay M; Riley G; Ackland S; Simpson A; Isaacs R; McKeage MJ Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):677-82. PubMed ID: 15554907 [TBL] [Abstract][Full Text] [Related]
4. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies. Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190 [TBL] [Abstract][Full Text] [Related]
5. Current role of LC-MS in therapeutic drug monitoring. Saint-Marcoux F; Sauvage FL; Marquet P Anal Bioanal Chem; 2007 Aug; 388(7):1327-49. PubMed ID: 17520242 [TBL] [Abstract][Full Text] [Related]
6. A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery. Yu S; Li S; Yang H; Lee F; Wu JT; Qian MG Rapid Commun Mass Spectrom; 2005; 19(2):250-4. PubMed ID: 15609367 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of targeted anticancer therapy. Decosterd LA; Widmer N; Zaman K; Cardoso E; Buclin T; Csajka C Biomark Med; 2015; 9(9):887-93. PubMed ID: 26333311 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer. Wattanatorn W; McLeod HL; Macklon F; Reid M; Kendle KE; Cassidy J Pharmacotherapy; 1997; 17(5):881-6. PubMed ID: 9324177 [TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry in the pharmacokinetic studies of anticancer natural products. Crotti S; Posocco B; Marangon E; Nitti D; Toffoli G; Agostini M Mass Spectrom Rev; 2017 Mar; 36(2):213-251. PubMed ID: 26280357 [TBL] [Abstract][Full Text] [Related]
10. Application of micellar liquid chromatography for the determination of antitumoral and antiretroviral drugs in plasma. Peris-Vicente J; Casas-Breva I; Roca-Genovés P; Esteve-Romero J Bioanalysis; 2014; 6(14):1975-88. PubMed ID: 25158967 [TBL] [Abstract][Full Text] [Related]
11. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics. Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915 [TBL] [Abstract][Full Text] [Related]
12. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of an HPLC-UV method for sorafenib quantification in human plasma and application to patients with cancer in routine clinical practice. Escudero-Ortiz V; Pérez-Ruixo JJ; Valenzuela B Ther Drug Monit; 2014 Jun; 36(3):317-25. PubMed ID: 24365980 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Drug Monitoring in Neonates: What Makes them Unique? Mian P; Flint RB; Tibboel D; van den Anker JN; Allegaert K; Koch BCP Curr Pharm Des; 2017; 23(38):5790-5800. PubMed ID: 28950825 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma. Bobin-Dubigeon C; Amiand MB; Herrenknecht C; Bard JM J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2451-6. PubMed ID: 19560408 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of intracellular anti-infective agents. D'Avolio A; Pensi D; Baietto L; Di Perri G J Pharm Biomed Anal; 2014 Dec; 101():183-93. PubMed ID: 24768264 [TBL] [Abstract][Full Text] [Related]
18. [Principles of therapeutic drug monitoring]. Widmer N; Csajka C; Werner D; Grouzmann E; Decosterd LA; Eap CB; Biollaz J; Buclin T Rev Med Suisse; 2008 Jul; 4(165):1644-8. PubMed ID: 18767290 [TBL] [Abstract][Full Text] [Related]
19. Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology. Dahmane E; Boccard J; Csajka C; Rudaz S; Décosterd L; Genin E; Duretz B; Bromirski M; Zaman K; Testa B; Rochat B Anal Bioanal Chem; 2014 Apr; 406(11):2627-40. PubMed ID: 24633563 [TBL] [Abstract][Full Text] [Related]
20. An introduction to drug testing: the expanding role of mass spectrometry. Hammett-Stabler C; Cotten SW Methods Mol Biol; 2012; 902():1-13. PubMed ID: 22767103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]